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ABSTRACT
Transgenesis is a cornerstone of molecular biology.
The ability to integrate a specifically engineered
piece of DNA into the genome of a living system
is fundamental to our efforts to understand life
and exploit its implications for medicine, nanotech-
nology and bioprospecting. However, transgenesis
has been hampered by position effects and
multi-copy integration problems, which are mainly
due to the use of small, plasmid-based transgenes.
Large transgenes based on native genomic regions
cloned into bacterial artificial chromosomes (BACs)
circumvent these problems but are prone to frag-
mentation. Herein, we report that contrary to
widely held notions, large BAC-sized constructs do
not prohibit transposition. We also report the first
reliable method for BAC transgenesis in human em-
bryonic stem cells (hESCs). The PiggyBac or
Sleeping Beauty transposon inverted repeats were
integrated into BAC vectors by recombineering,
followed by co-lipofection with the corresponding
transposase in hESCs to generate robust fluores-
cent protein reporter lines for OCT4, NANOG,
GATA4 and PAX6. BAC transposition delivers
several advantages, including increased fre-
quencies of single-copy, full-length integration,
which will be useful in all transgenic systems but
especially in difficult venues like hESCs.
INTRODUCTION
Early work on transgenesis in animals and cell lines in-
variably used small transgenes, which only rarely achieved
the intended expression pattern due mainly to position
effects exerted by the genomic integration site or
concatamerization. These major problems have been cir-
cumvented by the use of large transgenes such as bacterial
artiﬁcial chromosomes (BACs), which carry intact
genomic regions and often deliver the expected expression
pattern precisely (1).
Due to their large size, BACs can accommodate complete
genes including all cis-regulatory elements in their native
conﬁguration. Consequently, most BAC transgenes are
indifferent to position effects and often deliver expression
levels in proportion to the transgene copy number. Many
BAC libraries have been annotated onto genome browsers
and are readily available from genome resource providers
such as CHORI (www.chori.org). Furthermore, BACs
can be readily modiﬁed and mutated using recombineering
(2–5). These advantages have promoted BACs to the fore-
front as transgenic tools and now BAC transgenesis
has been successfully applied to produce a variety of trans-
genic animals, such as mice, rats, zebraﬁsh and ﬂies (6–9),
as well as for studies of gene function, molecular comple-
mentation of mutations, identiﬁcation of distant regula-
tory elements and analysis of gene dosage, among other
applications (1,10–13). Because they often recapitulate ex-
pression patterns precisely, BAC transgenes are also
widely used to create gene expression reporters for
studies during development and differentiation.
Human embryonic stem cells (hESCs) (14) provide an
essential venue for studies of human development and
disease that complements work with model systems such
as the mouse. Like mouse ESCs (mESCs), they can be
differentiated in culture to recapitulate aspects of human
embryology and to serve as paradigms for future medicine
with cellular therapies. However, they are difﬁcult to mani-
pulate genetically, particularly for gene targeting (15–17).
The work reported here began with our efforts to create
stable hESC reporter lines based on ﬂuorescent protein
expression driven by stage- and lineage-speciﬁc promoters.
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Although we were able to create an OCT4-GFP reporter
line by gene targeting (data not shown), the efﬁciency of
homologous recombination in hESCs is low (15,16) and
our attempts to generate a knock-in for lineage-speciﬁc
genes have not been successful. On the other hand, ran-
domly integrated retroviral and small transgenes often
undergo transcriptional silencing in hESCs (17–19).
Consequently, we were attracted by the advantages of
BAC transgenesis and used the only published method
for BAC transgenesis in hESCs, which is based on
nucleofection (20). Unexpectedly, transgene silencing was
consistently observed, which we correlated with consistent
failures to obtain integrations of full-length BAC trans-
genes. To solve the problem of BAC fragmentation, we
explored the possibility that transposition could be used to
integrate full-length BAC transgenes.
DNA transposons are mobile elements that contain
inverted terminal repeats (ITRs), which are recognition
sites for a transposase that cuts at the outside end of the
inverted repeats and moves the excised DNA into a new
site. Transposons have been used for insertional mutagen-
esis and gene transfer in many model organisms. However,
applications in vertebrates were impeded due to the lack
of active transposons until Tol2 was isolated from the
Japanese Medaka ﬁsh Oryzias latipes (21,22) and Sleeping
Beauty (SB) was reactivated from the salmon genomeby the
elimination of phylogenetically identiﬁed mutations
(23,24). In 2005, PiggyBac transposon isolated from the
cabbage looper moth Trichoplusia ni was reported to be
active in mammalian cells including mouse and human
(25). Consequently, several options for transposition in
ﬁsh,mouse andhumancells are nowavailable. Inparticular,
SB and PiggyBac appear most useful (26–31) and increased
activity variants of both have been recently identiﬁed (32).
Notably, transposase-mediated transgenesis has been
used in cells that are difﬁcult to transfect including human
haematopoietic stem cells (32,33) and hESCs (34–36).
Consequently, we were encouraged to examine whether
BAC transgenesis in hESCs could be facilitated by trans-
position. However, transposons appear to have severe size
limitations (37), which have limited their use for large
transgenes.
During attempts to integrate large (up to 60 kb) trans-
genes into Myxococcus and Pseudomonas prokaryotic
hosts, we encountered problems with fragmentation,
which we solved by use of transposition (38). Further-
more, Tol2 transposition has been used to integrate a
66 kb transgene into zebraﬁsh and mouse genomes (39).
These studies indicate that fears about the size limitations
of transposons may be misguided. Herein, we show that
transposition can be applied to integrate full-length BACs
larger than 150 kb into hESCs, which has implications for
BAC transgenesis in general and particularly in systems
that are difﬁcult to work with.
MATERIALS AND METHODS
Generation of large reporter constructs and BAC reporters
The large constructs were made by subcloning from
the respective BACs a region of 19 kb for hOCT4 gene
and 25 kb for hNANOG into a plasmid with p15A origin
of replication using recombineering technology
(Supplementary Figure S1) (2,3). For the generation of
large construct or BAC reporters, the green ﬂuorescent
protein (GFP) or Cherry cassettes were inserted directly
after the initiating methionine (ATG) of the respective
gene using recombineering. The PiggyBac or SB
terminal repeats were inserted into different positions of
the BAC backbone using a universal recombineering
strategy applicable to most of the common used BAC
vectors (Supplementary Figure S2). The recombineering
details and list of oligos are presented in Supplementary
Experimental Procedures.
hESC culturing
H7.S6 and H9 hESCs were cultured on mouse embryonic
ﬁbroblasts (MEFs) in DMEM/F12 medium supplemented
with 20% Knockout Serum Replacement (Invitrogen)
and 4 ng/ml basic ﬁbroblast growth factor (bFGF)
(Peprotech) and passaged using 1mg/ml collagenase IV
(Invitrogen) adding 10 mM Rho-associated kinase
(ROCK) inhibitor Y-27632 (40). For transfections and
differentiation assays, the cells were transferred to
feeder-free conditions on Matrigel (BD Biosciences) in
MEF-conditioned hESC medium, and propagated using
TrypLE (Invitrogen).
Transfections of hESCs
Electroporation of large constructs into hESCs was
performed according to the standard protocol at 320V
and 250 mF (15). BAC transfection was performed either
by nucleofection (20) or lipofection. hOCT4-GFP,
hNANOG-GFP, hPAX6-GFP and hGATA4-GFP
BACs were prepared using Nucleobond BAC 100 kit
(Macherey-Nagel). Nucleofection was done in 100 ml of
solution V using program B-016 according to manufac-
turer protocol (Amaxa). 5 106 of cells were nucleofected
with 5 mg of the BAC and 300 ng of the transposase ex-
pression or control vector.
For lipofection, hESCs were split to Matrigel-coated
dishes in the ratio 1:3, 1 day before transfection. 3, 10,
30 or 50 mg of BAC and 3 or 10 mg of the transposase
expression or control vector were used for lipofection of
a 10 cm dish with hESCs using Lipofectamine LTX
(Invitrogen) according to manufacturer protocol.
Selection with G418 (100 mg/ml; Invitrogen), puromycin
(0.5 mg/ml; Sigma) or blasticidin (2 mg/ml; Invitrogen)
started 2 days after transfection. After 14 days of selec-
tion, stable resistant clones were picked to 96-well plates
and expanded.
Polymerase chain reaction analysis of hESC clones
Genomic DNA from the hESCs clones was prepared
directly in 96-well plates and used for screening by
polymerase chain reaction (PCR) for the presence of trans-
poson inverted repeats and loss of ampicillin/spectino-
mycin cassette that occurs during transposition. The
clones that contained a BAC integrated by transposase
according to PCR analysis (PB5+ Amp PB3+ or SB5+
Spec SB3+) were checked for the BAC copy number by
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quantitative PCR (qPCR). Five to six pairs of primers
were designed along each BAC randomly with the
distance 30–40 kb between primer pairs (listed in
Supplementary Experimental Procedures). The copy
number was calculated by normalization of Ct-values for
each primer pair to GAPDH gene relatively to wild-type
cells, which contain two allelic copies of each genomic
region.
Splinkerette PCR
The integration sites of BACs in the clones were deter-
mined using splinkerette PCR (41). Genomic DNA
digested with ApoI or BstYI was ligated to 75 nM
splinkerette adaptor (SPLK-A and SPLK-ApoI/BstYI).
The 50- and 30-junctions were ampliﬁed using nested
PCR and sequenced.
Differentiation of hESCs
For differentiation of H7.S6 hOCT4-GFP clones, bFGF
was removed from the cultured medium for 10 days and
then GFP expression was analysed by ﬂow cytometry.
H7.S6 hPAX6-GFP clones and wild-type cells were
differentiated to neural epithelial cells (42,43). Embryoid
bodies (EBs) were formed in N2B27 medium with 10 mM
transforming growth factor beta (TGFb) receptor inhibi-
tor SB431542 (Tocris). After 8 days, EBs were spread to
tissue culture dishes coated with 100 mg/ml polyornithine
and 10 mg/ml laminin (Sigma–Aldrich). Expression of
PAX6 and GFP was checked by ﬂow cytometry or im-
munocytochemistry on Day 14 of differentiation.
H7.S6 hGATA4-GFP clones and wild-type cells were
differentiated to deﬁnitive endoderm (44). RPMI supple-
mented with B27 (1), 1mM sodium butyrate, 100 ng/ml
activin A and 25 ng/ml Wnt3a (both from Peprotech) was
used for the ﬁrst day of differentiation. Next day, Wnt3a
was omitted from the medium, and the cells were cultured
further in RPMI with B27 (1), 0.5mM sodium butyrate
and 100 ng/ml activin A. On Day 7, the cells were analysed
for GFP and CXCR4 expression by ﬂow cytometry, and
for markers expression by qPCR.
Immunostaining and microscopy
The incubation with primary antibodies was for 1 h at
room temperature with mouse anti-Oct4 (1:50, sc-5279;
Santa Cruz), rabbit anti-Nanog (1:30, AB5731;
Chemicon) or overnight at +4C with mouse anti-Pax6
(1:30; Developmental Studies Hybridoma Bank). The cells
were incubated with secondary antibodies diluted 1:500
(FITC goat anti-rabbit and TRITC goat anti-mouse;
Jackson Immunoresearch Laboratories and Alexa633
goat anti-mouse; Molecular Probes, Invitrogen) for 1 h at
room temperature. Fluorescence images were taken using
Leica SP5 laser scanning confocal microscope.
Flow cytometry
The cells were dissociated and ﬁxed in phosphate buffered
saline (PBS) with 1% formaldehyde. For antibody
staining, 106 of live cells were incubated with
R-Phycoerythrin (PE)-conjugated anti-CD184 or
immunoglobulin G (IgG) isotype control (BD
Biosciences) diluted 1:100 in PBS with 2% fetal calf
serum (FCS) for 30min at+4C. The cells were analysed
with ﬂow cytometer LSR II (Becton Dickinson) using
FACSDiva software. The data were processed with
FloJo software.
RESULTS
Generation of OCT4 and NANOG ﬂuorescent reporter
H7.S6 cells using large constructs
To study pluripotency, lineage commitment and differen-
tiation pathways in hESCs, we aimed to create a panel of
reporter cell lines based on the expression of ﬂuorescent
proteins under control of selected promoters. Using
recombineering, genomic regions containing the OCT4
and NANOG genes (19 and 25 kb, respectively) were
subcloned from BACs and GFP or mCherry IRES
neomycin cassettes were inserted at the initiating methio-
nine codon (Figure 1a and Supplementary Figure S1).
Stable H7.S6 hESC clones were established after electro-
poration and G418 selection. However, we failed to obtain
clones with uniform expression of the reporters, despite
the fact that OCT4 and NANOG are expressed in undif-
ferentiated hESCs. All clones (n=8) showed mosaic ex-
pression (59.9–85.0% positive cells by ﬂow cytometry),
which was further reduced when G418 selection pressure
was removed. However, the non-ﬂuorescent cells were not
differentiated, as shown by staining with OCT4 and
NANOG antibodies (Figure 1b). We also generated
double stable reporter lines after a second round of elec-
troporation. The double reporter clones H7.S6
OCT4-mCherry/OCT4-GFP and NANOG-mCherry/
NANOG-GFP also displayed mosaic expression of both
ﬂuorescent transgenes, which only partially overlapped
(Figure 1c), indicating that even these relatively large
transgenes undergo random silencing.
Generation of hESC BAC reporters using PiggyBac
transposition
To circumvent silencing, we decided to use BAC trans-
genes. BACs containing OCT4 and NANOG genes were
modiﬁed with the GFP-IRES-neo-pA reporter cassettes
and stable hESC clones were established using
nucleofection (20). However, once again we observed
mosaic expression (data not shown). Because small trans-
posons have been shown to mediate efﬁcient gene transfer
in mESC, hESC and human cell lines (25,29,34–36), we
decided to evaluate whether transposition could be
applied to BAC transgenesis. Among several transposons,
we ﬁrst chose PiggyBac based on its reported efﬁciencies
in mammalian cells (26,45). The OCT4 and NANOG
BACs were further recombineered to insert a cassette
into the BAC backbone that contained the PiggyBac
ITRs (50-313 bp, 30-235 bp (46)); ﬂanking an ampicillin re-
sistance gene. For this purpose, we built a recombineering
cassette in an R6K plasmid so that PacI or PacI/AscI
restriction digestion releases a fragment that will recom-
bine with most common human and mouse BAC vectors;
pBACe3.6, pBeloBAC11, pTARBAC1, pTARBAC1.3,
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Figure 1. H7.S6 OCT4 and NANOG reporter lines created by existing transgenic methods show mosaic expression, highlighting the need for BAC
transgenes. (a) Stable H7.S6 hESC clones carrying 19 kb OCT4 or 25 kb NANOG reporter transgenes to express mCherry or GFP IRES neo reporter
cassettes (see also Supplementary Figure S1), exhibited mosaic expression as determined by ﬂuorescent imaging (left panels) or ﬂow cytometry (FACS
scans at the right). Fluorescent protein expression from the transgenes fell upon removal of G418 selection (compare +G418 with –G418 FACS
panels). (b) Immunostaining of H7.S6 OCT4-mCherry and NANOG-mCherry reporter lines (63, zoom) for endogenous OCT4 or NANOG
expression showed that most cells expressed the endogenous proteins but many did not express the ﬂuorescent reporter (arrowheads), indicating
that the mosaic expression was due to silencing of the transgene and not differentiation of the cells. (c) Double stable reporter H7.S6
OCT4-mCherry/OCT4-GFP and NANOG-mCherry/NANOG-GFP lines were generated after transfecting the single OCT4 and NANOG reporters
above. Both OCT4 and NANOG double mCherry/GFP reporters showed partially overlapping mosaicism, indicating random silencing of the
reporter. Arrows and asterisk show cells that exhibited only GFP or mCherry ﬂuorescence, respectively.
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pTARBAC2, pTARBAC2.1 and pTARBAC6 (Figure 2a
and Supplementary Figure S2). Then, the OCT4-GFP and
NANOG-GFP BACs were transfected into H7.S6 hESCs
using either nucleofection or lipofection, with or without
co-transfected codon optimized PiggyBac transposase ex-
pression plasmid, mPBase (47). Without co-transfected
mPBase, both transfection methods produced a similar
number of resistant colonies (22 and 16 clones for
OCT4-GFP and 5 and 4 clones for NANOG-GFP per
107 transfected cells; Table 1 and Supplementary Table
S1). With nucleofection, co-transfection of mPBase did
not increase the colony number (29 resistant clones for
OCT4-GFP and 3 clones for NANOG-GFP). However,
co-lipofection of mPBase produced more colonies for both
BACs (413 for OCT4-GFP and 14 for NANOG-GFP).
To check whether the BACs had been integrated by
transposition, we established a PCR-based strategy for
colony screening based on primers directed to the
PiggyBac ITRs (PB5 and PB3) and the ampicillin (Amp)
gene (Figure 2b). Transposition should integrate the ITRs
yet exclude the ampicillin gene, whereas random integra-
tion with or without fragmentation could give any com-
bination of PCR signals. Most of the colonies established
by nucleofection, with or without mPBase, contained
either the whole PiggyBac cassette (PB3+ Amp+ PB5+)
or none of it (PB3 Amp PB5). The same was
observed for the lipofection of the BACs alone (Table 1
and Supplementary Table S1). Notably, only lipofection
with mPBase resulted in clones that had the signature of
transposition (PB3+Amp PB5+; 18.8% of OCT4-GFP
and 75% of NANOG-GFP clones). Characterization of
clones obtained from nucleofection with or without
mPBase indicated that all contained only limited pieces
of the BAC and none of them was due to transposition,
suggesting that nucleofection breaks BACs.
Given these encouraging results, we generated BAC
transposon GFP reporters for the lineage-speciﬁc genes
PAX6 and GATA4 and lipofected them into H7.S6 cells
with or without mPBase. Because these genes are not ex-
pressed in hESCs, the IRES could not be used to drive
neomycin resistance so we used the PGK promoter, which
consequently provided similar efﬁciencies for both trans-
fections (Table 1 and Supplementary Table S1).
Application of the mPBase resulted in 1.7-fold increase
of the colony number for both GATA4 and PAX6
BACs, and about one-third of those clones gave the trans-
positional signature. The use of the hyperactive version of
PBase, hyPBase (48), further increased the total number of
colonies and the proportion of transpositional events
(61.7%). These lipofection results were essentially
(a)
(b)
Figure 2. BAC transgenesis using PiggyBac transposition. (a) Human BACs were modiﬁed by recombineering with GFP reporter cassettes that were
inserted directly after the start codon (ATG) and contained a selectable marker expressed either by the gene promoter (for genes expressed in
hESCs), or by PGK promoter (for genes that are not expressed in hESCs). The ﬁgure shows the hNANOG example, which is expressed in hESCs.
A second recombineering step inserted a standardized cassette containing PiggyBac ITRs (PB5 and PB3) ﬂanking the ampicillin resistance gene
(Amp) into the BAC backbone. The PiggyBac ITR/ampicillin cassette was cloned into an R6K vector so that PacI/AscI digestion releases a
restriction fragment that is ﬂanked by homology regions that will recombine with most BAC vectors. The modiﬁed BACs were co-transfected
with a PiggyBac transposase (mPBase) expression plasmid into hESCs. (b) Transposition of the BAC by PiggyBac will be full-length, ﬂanked by
the ITRs and ampR will be omitted. Hence, PCR assays for the presence of PB5 and PB3 with simultaneous loss of Amp indicates transposition.
The copy number of the BAC was determined by quantitative, allele counting PCR (qPCR) on the genomic DNA using 5–6 primer pairs at about
30–40 kb intervals along the BAC (a–e).
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reproduced using another hESC line, H9 (Table 1 and
Supplementary Table S1), which is more difﬁcult to trans-
fect (our unpublished data). The optimum ratio of BAC
transgene to PBase expression vector was evaluated
(Supplementary Table S2). In most cases, 10–30mg BAC
with 3–10 mg PBase per 10 cm dish (3 106 cells), which
corresponds to molar ratios of BAC to PBase from 1:9 to
1:30, gave the most colonies.
Furthermore, we generated a PAX6-GFP reporter BAC
that contained PiggyBac ITRs ﬂanking the vector
backbone (ca. 9.5 kb apart from each other). This version
also contained the Blasticidin resistance gene driven by the
ubiquitin C promoter at one end of the genomic sequence
next to the PiggyBac 30-ITR (Supplementary Figure S2).
Transposition by PBase (mPBase or hyPBase) resulted in
clones that contained integrated BAC without the vector
backbone, albeit with apparent lower efﬁciency. Thus,
PiggyBac transposition can be used to exclude integration
of the prokaryotic vector sequences into the genome.
Copy number of BAC integrations
To further characterize the BAC integrations, we analysed
OCT4-GFP, GATA4-GFP and PAX6-GFP hESC clones
for transgene copy number using qPCR on genomic
DNA. Primer pairs were selected across the full-length
BAC at a distance of 30–40 kb from each other (Figures
2b and 3). The Ct-values were normalized to wild-type
DNA to calculate the number of additional copies
arising from the integrated transgenes.
We analysed 17 clones positive for the transpositional
signature (PB5+ Amp PB3+; Figure 3). Most clones
showed single-copy signals for all primer pairs indicative
of a single transpositional event (12/17; 70.5%). A further
three clones showed full-length, multi-copy integrations
(three, two and four copies) suggesting multiple
transpositional events. The remaining two clones showed
signs of a partial integration of a second copy in addition
to a single full-length copy, suggesting a combination of a
single transpositional event and a partial random event. In
addition, we characterized 19 clones that did not present
the transpositional signature (either PB5+Amp+PB3+or
PB5 Amp PB3; Figure 3b). Most of these clones had
missing or inconsistent signals for at least one primer pair
indicating random integration of fragments.
Analysis of integration sites of the BACs
The integration sites were examined by splinkerette PCR
and sequencing (41). We analysed 21 H7.S6 clones
(including OCT4-GFP, OCT4-mCherry, NANOG-GFP,
PAX6-GFP, SOX1-GFP and GATA4-GFP) and 4 H9
clones that were positive for the transpositional signature.
In all cases, the integration locus was continuous on the 50-
and 30-sides of a duplicated TTAA sequence (Table 2),
which is characteristic of PiggyBac insertion sites (49).
As controls we analysed the junctions of PiggyBac ITRs
in several PB3+Amp+PB5+clones that were established
by transfection of the BAC without mPBase. As expected,
the PiggyBac ITRs were followed by the ampicillin gene
sequence and not genomic DNA, consistent with random
integration of the BAC (data not shown).
Previous studies showed that the PiggyBac transposon
can integrate into any chromosome with a preference for
Table 1. Summary of BAC transgenesis and transpositions. H7.S6 and H9 hES clones were screened for the PiggyBac transpositional signature
by PCR after nucleofection or lipofection with or without a PBase expression construct (either mPBase or hyPBase) as indicated
Transposition events
(PB3+ Amp PB5+)
N analysed N total
Nucleofection H7.S6 OCT4 (IRES-neo) 149 kb BAC 0 10 22
BAC+mPBase 0 18 29
H7.S6 NANOG (IRES-neo) 164 kb BAC 0 1 5
BAC+mPBase 0 2 3
Lipofection H7.S6 OCT4 (IRES-neo) 149 kb BAC 0 12 16
BAC+mPBase 9 (18.8%) 48 413
H7.S6 NANOG (IRES-neo) 164 kb BAC 0 2 4
BAC+mPBase 6 (75%) 8 14
H7.S6 GATA4 (PGK-neo) 196 kb BAC 0 20 130
BAC+mPBase 16 (36.4%) 44 222
H7.S6 PAX6 (PGK-neo) 150 kb BAC 0 24 120
BAC+mPBase 17 (37.8%) 45 200
BAC+hyPBase 21 (61.7%) 34 454
H7.S6 PAX6 (PGK-neo) ITR-backbone 150 kb BAC 0 8 8
BAC+mPBase 3 (11.5%) 26 35
BAC+hyPBase 28 (50.0%) 56 83
H7.S6 PAX6 (UbiC-BSD) ITR-backbone 150 kb BAC+hyPBase 41 (43.2%) 95 240
H9 PAX6 (PGK-neo) 150 kb BAC+hyPBase 55 (57.3%) 96 201
All BACs contained a GFP reporter integrated at the initiating ATG codon and the antibiotic resistance gene for selection either under an IRES
(for OCT4 and NANOG) or expressed from the PGK or UbiC promoter (for GATA4 and PAX6). The BAC sizes are indicated. The
PiggyBac inverted repeats either ﬂanked the AmpR gene (1 kb apart) or the whole BAC backbone (9.5 kb apart—indicated as ‘ITR backbone’).
The data in the transpositional events column show the number and percentage of clones positive for the transpositional signature. ‘N analysed’
presents the number of clones that were screened for the transpositional signature and ‘N total’ presents the yield of clones per 107 transfected cells in
that experiment.
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AT-rich sequences within 10 kb from transcription units
(25,29,34). We analysed the sites of integrations of the
BACs and they were either located in intergenic (n=14)
or intronic regions (n=11) (Table 2) without any obvious
chromosomal preference or DNA consensus around the
TTAA site of the integrations (Supplementary Figure S3).
Functionality of the reporter clones
The integrity of the reporter BAC transgenes after trans-
position into hESCs can be functionally evaluated.
Various clones were examined for the stability and
pattern of expression before and after differentiation.
Using single-copy OCT4-GFP clones integrated by
mPBase (n=7), we found that all clones uniformly ex-
pressed GFP (99%) in the undifferentiated state in the
presence of G418 and notably after >1 month of culture
without G418 selection pressure (96.13%; Figure 4a). The
clones were induced to differentiate by bFGF removal
(50,51) leading to the loss of GFP expression after 8
days. Hence, the OCT4-GFP BAC transgenes integrated
by transposition are functional, reliable and not prone to
position effects.
To validate lineage reporters for the genes that are not
expressed in hESCs, we used PAX6-GFP and GATA4-
GFP BAC transfected clones, created by transposition.
H7.S6 PAX6-GFP cells were differentiated into neural
epithelium cells in N2B27 through EBs in the presence
of TGFb receptor inhibitor (42,43). The attached EBs
formed neural rosettes, which is the characteristic
phenotype for neural progenitor cells. 74.81% of the
cells were GFP positive and co-expressed GFP with en-
dogenous PAX6 as shown by ﬂow cytometry and
immunostaining (Figure 4b).
H7.S6 GATA4-GFP BAC reporter cells were used
to generate deﬁnitive endoderm by treatment with a
high concentration of activin A (44). Quantitative
reverse transcription–PCR (qRT–PCR) conﬁrmed
up-regulation of the endodermal markers GATA4,
SOX17 and FOXA2 after 7 days of differentiation
(Figure 4c). Most (83.67%) cells were GFP positive and
co-expressed the marker of deﬁnitive endoderm CXCR4
shown by ﬂow cytometry. Interestingly, the dynamic of
the reporter expression closely reproduced recent observa-
tions on deﬁnitive endoderm differentiation, which
(a)
(b)
Figure 3. BAC transgene copy number and integrity in H7.S6 hESC clones containing OCT4-, GATA4- and PAX6-GFP reporters. Copy number
was evaluated by qPCR assays similar to that illustrated in Figure 2b. (a) Results from 17 clones that were positive for the transpositional signature
(PB5+Amp PB3+) are depicted. (b) Results from clones that did not present the transpositional signature, including nine from experiments with
co-lipofected transposase expression plasmid (+mPBase) and 10 from experiments without co-transfected mPBase (mPBase). The bars show the
additional copy number for each primer pair in the clones and the transpositional signature results are shown below.
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(a)
(b)
(c)
Figure 4. Validation of H7.S6 BAC transposon reporter lines. H7.S6 clones containing veriﬁed PiggyBac BAC transpositions for OCT4-GFP,
PAX6-GFP and GATA4-GFP reporters were analyzed. (a) An H7.S6 OCT4-GFP reporter clone showed homogeneous expression of the transgene
as evaluated by immunoﬂuorescence (panels at left) and ﬂow cytometry (+G418 FACS panel). GFP expression was without selection pressure
in undifferentiated cells (G418 FACS panel). After differentiation for 8 days, GFP expression was uniformly down-regulated (bottom right
FACS panel). (b) An H7.S6 PAX6-GFP reporter clone did not express any ﬂuorescence before differentiation (FACS panel—undifferentiated).
After 10 days of differentiation to neural epithelial cells, most cells in rosette-like structures (74.81%; FACS panel—differentiated) expressed GFP,
which co-localized with endogenous Pax6 by immunoﬂuorescence. (c) An H7.S6 GATA4-GFP reporter clone and the parental H7S6 line were
differentiated to deﬁnitive endoderm cells for 7 days and gene expression was compared with undifferentiated cells for selected genes. CXCR4
expression was evaluated by FACS (left hand panels). OCT4, GATA4, FOXA2, GFP, SOX17 and GAPDH levels were compared by qRT–PCR
(right hand panels).
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showed that GATA4 expression preceeds CXCR4 (52)
(data not shown). These data support the conclusion
that the BAC transposon reporters are functional and
faithfully reproduce endogenous patterns of gene expres-
sion during differentiation.
Sleeping Beauty BAC transposition
To determine whether the ability to transpose a very large
cargo was a feature of PiggyBac, we undertook BAC
transposon experiments with SB (Supplementary Figure
S4). SB ITRs, separated by a spectinomycin resistance
gene, were inserted into the PAX6-GFP BAC vector and
co-lipofected with SB100xco transposase (a human codon
optimized version provided by Zsuzsanna Izsvak). The
combination of BAC and transposase expression
plasmid resulted in >20-fold increase in the colony
number compared with the control co-transfection of
BAC with catalytic mutant of transposase (D3 construct).
PCR screening identiﬁed the clones with transpositional
signature (23/32; 72%) and most of them contained a
single copy of the BAC. We mapped the transgene pos-
itions in three clones and conﬁrmed a TA integration site
that is characteristic for SB transposition (Supplementary
Figure S4).
DISCUSSION
All genomes from bacterial to mammalian have been
bombarded by transposons. Consequently, transposons
have been widely successful as transgenic vehicles and
genetic tools in many cell types and organisms (7,8,24).
However, applications have been almost entirely limited
to transposons with small cargos due to the facts that the
majority of natural transposons are <2 kb long and larger
cargos appear to suppress transposition. Indeed, many
studies have described an inverse length dependence of
transpositional efﬁciency in the range of 30–50% per
each extra kilobase of transposon size (37,53–55). In
apparent contradiction to this literature, transpositions
of 60 kb transgenes were reported using ‘MycoMar’
transposon in prokaryotic hosts by our group (38) and
Tol2 in zebraﬁsh and mice by others (39). Furthermore,
recent model experiments in mESCs reported BAC trans-
positions up to 100 kb using PiggyBac (56). The question
therefore arises: if transposition with very large cargos is
possible, how can this apparent contradiction be resolved?
The answer may lie with the suggestion that transposon
length dependence is determined by the shortest distance
between the ITRs, regardless of the orientation inside or
outside the transposon (57). In this case, the transposons
reported here are efﬁcient because the ITRs are only 1 kb
apart and the transposase is largely indifferent to the
100 kb+ size of the cargo (Supplementary Figure S5).
Consistent with this proposition, we observed similar
efﬁciencies of transposition for the BACs that contained
the same cassette for the selection of resistant clones
(PGK-neo-pA), regardless of the cargo size difference
(PAX6, 150 kb and GATA4, 196 kb; Figure 2 and Table
1). Furthermore, experiments using the BACs with
increased distance between the ITRs (when placed at
either end of the BAC vector to achieve transgene integra-
tion without the inclusion of prokaryotic vector se-
quences) indeed indicate a reduced efﬁciency (about 2–3-
fold reduced when the ITRs were spaced about 9.5 kb
apart; Table 1 and Supplementary Table S1). This explan-
ation also accounts for the observation that very different
types of transposases can mediate BAC transposition
[PiggyBac, SB/MycoMar and Tol2 come from three
distinct classes (23,25,58,59)]. It also suggests that there
is no inherent limitation for transposon cargo size,
which is an unanticipated conclusion.
The transposition mechanism implies that BAC trans-
posons must be covalently closed circular molecules when
transfected. It therefore follows that the quality of the
BAC DNA preparation will affect the ratio of transposon
to random integration events. Breaks in the BAC will tend
to promote random transgenesis whereas covalently
closed circles will favour transposition. In line with this
point, we only achieved BAC transposition by lipofection
and failed when nucleofection was used, apparently
because nucleofection promotes BAC breakage. Whether
electroporation also promotes breakage is unclear. We
note that Li et al. (56) used electroporation to achieve
BAC transpositions. It is also notable that Li et al.
achieved transpositions of BACs with the ITRs separated
by large distances. Because they use more elaborate proto-
cols, involving transfection of the PiggyBac expression
plasmid 3 days before electroporation of the BAC,
followed by positive and negative selection for transpos-
ition, it is not possible to deduce efﬁciencies that could be
compared with those reported here. We show that a much
simpler protocol based on co-lipofection and positive se-
lection only is sufﬁcient to achieve satisfactory frequencies
of BAC transposition when the ITRs are within 1 or a few
kb of each other.
BAC transgenesis by transposition brings three major
advantages over the widely used methods for BAC
transgenesis by random integration (60,61). For random
integration, the BAC can be transfected either after
linearization by restriction digestion or as uncut circles.
Linearization is useful because it determines how the
BAC integrates into the genome. In contrast the uncut
BAC needs to break, which can occur anywhere, before
integration. However, linearized BACs are more difﬁcult
to handle because they are prone to shearing. BAC trans-
position avoids this conundrum because the uncut BAC is
used and the site of integration on the BAC is determined
by the positions of the ITRs. Hence, the continuity of the
integrated BAC can be assured. Furthermore, as a trans-
poson, the BAC will be integrated as a single copy, which
ensures physiological expression and avoidance of tandem
repeat-associated silencing. (Note, as shown here, it is
possible to obtain cells that have more than one integrated
transposon; however these will almost always be inde-
pendent events resulting in single copies integrated at dif-
ferent genomic sites.) Furthermore, advantages over
random integration include the fact that transposition in-
creases the frequency of transgenesis, which is particularly
important for difﬁcult systems such as hESCs and that the
genomic integration site can be identiﬁed by a standard
splinkerette assay based on the ITRs. Because the
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splinkerette assay is laborious, for ease of detection we
developed a PCR assay for the transpositional signature
(PB5+ Amp PB3+), which can be applied for fast
screening of the clones in a large scale. All clones
positive for the signature that we also examined by
splinkerette sequencing were bona ﬁde transpositions.
Hence, we suggest that BAC transpositions can be
evaluated using this convenient PCR test with high conﬁ-
dence. Given these many advantages, and because we
show that BAC transposition requires no additional trans-
fection steps when compared with random transgenesis,
we strongly recommend that all applications of BAC
transgenesis now use transposition.
To facilitate this recommendation, we made PiggyBac
and SB ITR cassettes ﬂanked by homologies to the
BAC vector in R6K plasmids for ease of recombineering.
R6K vectors do not replicate in common Escherichia coli
hosts; hence, the most common source of recombineering
background is eliminated (62). These standardized ITR
cassettes are released by restriction digestion with PacI
and AscI, which permits asymmetric dephosphorylation
so that beta recombination can be applied to enhance
recombineering efﬁciency (63) (Supplementary Figure
S2). Whereas this is not necessary for normal applications,
it is relevant for high-throughput processing in recom-
bineering pipelines (64–66), which can now be applied to
existing BAC resources to rapidly convert them into
transposons.
We generated a panel of ﬂuorescent BAC reporter
hESCs, including SOX1 (data not shown), OCT4,
NANOG, GATA4 and PAX6. In almost all cases, the
clones showed the correct expression properties quantita-
tively and stably. For example, all seven OCT4 BAC trans-
poson hESC clones tested showed stable GFP expression
in the undifferentiated state after prolonged passaging
with or without selection pressure. This underlines the re-
liability of BAC transgenes when compared with, for
example, the lines generated here using quite large con-
structs (19–25 kb). Generation of reporter lines for genes
that are not expressed in hESCs is a particularly difﬁcult
task due to the silencing of the transgenes and so far this
has been achieved only in few cases by gene targeting (67–
71). Herein, we show with PAX6 and GATA4 hESC re-
porters that BAC transposition is a reliable way to estab-
lish hESC lines even for genes that are not expressed. To
our knowledge, this is the ﬁrst transgenic method that can
be reliably applied to access the power of hESCs for devel-
opmental and disease-modelling studies.
Our work brings a further advance in BAC transgenesis
in different organisms and cell types, especially those that
are recalcitrant to genetic modiﬁcations such as hESCs.
This technology includes the standardized insertion
of transposon ITR cassettes into the BAC backbone
using recombineering, co-delivery of the BAC with the
transposase and fast PCR screening for transpositions.
These steps are straightforward and achieve single-copy,
full-length, BAC integrations in genomic loci that can be
readily mapped, all of which we believe sets a new ideal for
transgenesis. Our work also unravelled a fundamental
property of transposition regarding the impact of cargo
size that has been underestimated in the past.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online: Sup-
plementary Tables 1 and 2, Supplementary Figures 1–5,
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